Legend: 
= Applied Session,
= Theme Session,
= Presenter, Sheraton Seattle Hotel & Towers = “S”
Washington State Convention & Trade Center = “CC”, Grand Hyatt Seattle = “H”
|
|
|
|
|
501
|
Thu, 8/10/06, 8:30 AM - 10:20 AM
|
CC-610
|
|
Theory and Application of Survival Analysis - Contributed - Papers
|
Section on Statistics in Epidemiology, Biometrics Section, ENAR
|
|
Chair(s): Patrick Tarwater, The University of Texas Health Science Center at Houston
|
|
8:35 AM
|
Proportional Hazards Model with Empirically Estimated Weights —  Qing Pan, University of Michigan; Douglas E. Schaubel, University of Michigan
|
|
8:50 AM
|
Power Estimation for Clearance of Live Vaccine Virus Using Weibull Survival Models with Interval Censoring — Daniel Zaccaro, Rho, Inc.; Barry Eggleston, Rho, Inc.; Susan Lieff, Rho, Inc.; Dennis Wallace, Rho, Inc.; Jon Hanifin, Oregon Health & Science University; Donald Leung, National Jewish Medical and Research Center; Marshall Plaut, National Institute of Allergy and Infectious Diseases; Erica Brittain, National Institute of Allergy and Infectious Diseases; Robert Holliday, Rho, Inc.; Mark Slifka, Oregon Health & Science University
|
|
9:05 AM
|
Comparison of Survival Methods and Polytomous Logistic Regression with Competing Risks — Robert Glynn, Brigham and Women's Hospital; Bernard Rosner, Harvard Medical School
|
|
9:20 AM
|
Software for Survival Analysis of Studies Nested within Cohorts To Estimate Relative, Absolute, and Attributable Risks — Hormuzd Katki, National Cancer Institute; Steven D. Mark, University of Colorado Health Sciences Center
|
|
9:35 AM
|
Population Attributable Risk in the Presence of Cure/Immune Individuals: a Simulation-Based Study — Jayawant Mandrekar, Mayo Clinic College of Medicine; Melvin L. Moeschberger, The Ohio State University
|
|
9:50 AM
|
Comparison of Methods to Model Mortality in the Presence of Time-Dependent Confounders — Ouhong Wang, Amgen Inc.; Trevor McMullan, Amgen Inc.
|
|
10:05 AM
|
Estimating Lifetime Risk Accounting for Baseline Prevalence: High Total Cholesterol in Framingham Heart Study — Michael Pencina, Boston University; Ralph B. D'Agostino, Boston University; Ramachandran S. Vasan, Framingham Heart Study; Alexa Beiser, Boston University; Mark R. Cobain, Unilever Corporate Research
|
| |
